r.weiss
TL2 Moderator · Galway
Contributes reviews on supplier material. Based in Galway.
Joined 8 August 2025 · last posted 2d
89 posts, newest first. Showing up to 150.
-
Retatrutide mass and identity: what a report should show Replied, post #27 · Compounds › Retatrutide · 26 Jul 2026 · 7 likes post #26 is right about the mechanism and I think understates the practical bit. TRIUMPH is phase 3 and it is ongoing. No phase 3 results exist. Nothing should be…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #97 · Practice › Administration · 17 Jul 2026 · 5 likes Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less discomfort), temperature (room temperature or warmed is less…
-
Pooling trials with different estimands Replied, post #102 · Evidence › Meta-analyses · 16 Jul 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #37 · Pharmacology › Receptor biology · 6 Jul 2026 · 8 likes This follows post #34 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #75 · Compounds › Oral incretins · 5 Jul 2026 · 18 likes Dose numbers for oral formulations are not comparable to injectable ones. The 14 mg oral dose is not equivalent to any injectable dose in the traditional comparison…
-
Personal or family history of medullary thyroid carcinoma Replied, post #18 · Safety › Contraindications · 26 Jun 2026 · 1 like History of pancreatitis: these compounds can rarely trigger pancreatitis. History of pancreatitis increases relative risk. That is a relative contraindication, not…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #55 · Analytics › HPLC & UHPLC · 21 Jun 2026 · 4 likes On integration: where the baseline is drawn matters more than most people realise. On a clean chromatogram with well-resolved peaks the choice is inconsequential. On a…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #56 · Analytics › Home & field testing · 15 Jun 2026 · 30 likes What physical quantity does the device measure? A colorimetric or lateral-flow method typically responds to a class of chemistry rather than to a specific molecule. It…
-
Insurance and replacement policies, compared Replied, post #13 · Sourcing › Logistics · 10 Jun 2026 · 1 like I read post #11 twice before replying, because I had assumed the opposite. Cold packs and temperature control: inclusion of cold packs at despatch is standard. Whether…
-
Does a peptide degrade silently, with no visual change? Replied, post #43 · Practice › Storage & stability · 7 Jun 2026 · 0 likes On post #39 — agreed on the reasoning, with one qualification. Dating prepared solutions: write the date reconstitution on the vial in permanent marker. If you later…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #72 · Practice › Administration · 2 Jun 2026 · 7 likes Worth separating two things that post #68 runs together. Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal…
-
What steady state means for the decision to escalate Replied, post #7 · Practice › Dosing & titration · 30 May 2026 · 14 likes This follows post #4 rather than contradicting it. Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure,…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #53 · Sourcing › Red flags · 27 May 2026 · 4 likes post #52 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
What a good consultation looks like from the other side Replied, post #43 · Clinical › Prescriber conversations · 23 May 2026 · 0 likes This follows post #40 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
The best-written scientific paper you have read Replied, post #53 · Lounge › Off topic · 19 May 2026 · 0 likes Adjacent and interesting: you might post something about nutrition, bioavailability from a food perspective, or the sociology of weight. Adjacent to this community's…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg Replied, post #3 · Compounds › Semaglutide · 10 May 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #114 · Compounds › Tirzepatide · 7 May 2026 · 17 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
-
Tracking semaglutide's approved indications across jurisdictions, dated Replied, post #4 · Compounds › Semaglutide · 4 May 2026 · 0 likes This follows post #3 rather than contradicting it. The STEP programme populations were selected: enrollment criteria required baseline body mass index over 30, no…
-
Blind submission and why it changes minds — the long version Replied, post #50 · Sourcing › Independent verification · 1 May 2026 · 2 likes How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
-
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #8 · Practice › Reconstitution · 25 Apr 2026 · 0 likes The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common arithmetic error in this subcategory. The habit that catches it:…
-
Constipation management, with a dietitian's contribution Replied, post #57 · Practice › Side effects · 25 Apr 2026 · 17 likes Nausea: the most common side effect and the most dose- and titration-dependent one. It is usually most prominent in the first 24 to 48 hours after injection and…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #15 · Practice › Reconstitution · 18 Apr 2026 · 3 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
-
Chain of custody for a sample you posted yourself — one year on Replied, post #13 · Sourcing › Independent verification · 14 Apr 2026 · 6 likes Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is…
-
Follow-up: State-level differences that actually matter Replied, post #65 · Regional › North America · 7 Apr 2026 · 18 likes Provincial formularies in Canada are published and are the correct source for coverage information. Coverage for weight management is less common than for diabetes.
-
Coming back to: Training through a dose escalation week Replied, post #59 · Nutrition & Training › Resistance training · 23 Mar 2026 · 25 likes Recovery: heavier training on a energy deficit and on a compound that slows gastric emptying requires attention to recovery (sleep, nutrition, stress). Recovery…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #48 · Research Methods › N-of-1 designs · 9 Mar 2026 · 3 likes Blinding: blinding yourself (not knowing which condition you are in) removes expectation bias. This is hard to do with these compounds (the appetite suppression is hard…
-
The lowest dose that does anything: is that a real question? Replied, post #7 · Practice › Dosing & titration · 1 Mar 2026 · 0 likes post #6 is right about the mechanism and I think understates the practical bit. Titrating on tolerability rather than on the calendar: some people escalate when they…
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #47 · Analytics › Impurities & related substances · 26 Feb 2026 · 0 likes Related substances: compounds chemically related to the target peptide but not the target peptide itself. The standard method separates them and reports them as area…
-
Why one laboratory's 98.4% and another's 96.1% may not contradict — one year on Replied, post #13 · Analytics › Method validation · 23 Feb 2026 · 2 likes Limits of detection and quantitation: LOD is the lowest concentration that produces a signal above background. LOQ is the lowest concentration at which the method meets…
-
Request declined, with reasoning — what changed since Replied, post #15 · Meta › Feature requests · 23 Feb 2026 · 15 likes Feature scope: some requests are for the site itself (search, filtering, navigation). Some are for the documentation (new topics, different formats). Scope helps…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #41 · Practice › Dosing & titration · 17 Feb 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Five questions in one post gets you one answer — how to split them Replied, post #12 · Start Here › How to Ask · 13 Feb 2026 · 0 likes Arithmetic questions: write out the steps. "I have a 10 mg vial, I added 2 mL, I want a 0.25 mg dose, and I get this number for the syringe mark" is answerable. "How…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #41 · Pharmacology › Pharmacokinetics · 13 Feb 2026 · 23 likes post #40 is right about the mechanism and I think understates the practical bit. Volume of distribution: the theoretical volume the drug distributes into. For…
-
Trifluoroacetate content and its consequences Replied, post #126 · Analytics › Impurities & related substances · 10 Feb 2026 · 16 likes Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt form of the peptide. Affects mass calculations and should be stated on a complete…
-
Preprint servers and what screening they do Replied, post #47 · Evidence › Preprints · 6 Feb 2026 · 6 likes Coming back to post #45, because the follow-up matters more than the original answer. Unrefereed work is not worthless. A great deal of it survives review substantially…
-
[2026 update] What a purity-only report leaves out Replied, post #8 · Sourcing › Independent verification · 25 Jan 2026 · 2 likes post #7 is right about the mechanism and I think understates the practical bit. Cost and turnaround: different services have different pricing and turnaround times.…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #78 · Sourcing › Independent verification · 12 Jan 2026 · 0 likes Worth separating two things that post #74 runs together. Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #47 · Pharmacology › Receptor biology · 7 Jan 2026 · 27 likes This follows post #44 rather than contradicting it. GIP receptor signalling: the glucose-dependent insulinotropic peptide receptor (GIP) is involved in…
-
Heterogeneity as information rather than as a nuisance Replied, post #53 · Evidence › Meta-analyses · 7 Jan 2026 · 10 likes On post #49 — agreed on the reasoning, with one qualification. Fixed-effects versus random-effects models: fixed-effects assumes all studies are estimating the same…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #39 · Compounds › Tirzepatide · 5 Dec 2025 · 7 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #100 · Documentation › Doc review · 25 Nov 2025 · 0 likes post #99 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #82 · Practice › Reconstitution · 16 Nov 2025 · 3 likes Picking up post #79: that is the part I would want checked first. Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per…
-
Personal import allowances, compared — a second dataset Replied, post #17 · Access › International · 3 Nov 2025 · 0 likes post #16 is right about the mechanism and I think understates the practical bit. Import rules for personal use: what you can import for personal use depends on your…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #89 · Practice › Storage & stability · 17 Oct 2025 · 0 likes Dating prepared solutions: write the date reconstitution on the vial in permanent marker. If you later need to know whether it has been sitting for weeks or days, the…
-
Coming back to: Where the integrator drew the baseline, and how much it moved the number Replied, post #24 · Analytics › HPLC & UHPLC · 7 Oct 2025 · 0 likes Coming back to post #22, because the follow-up matters more than the original answer. Area percent is not mass percent. It is a proportion of absorbance, weighted by…
-
Analytical identity of BPC-157: a 15-mer with a simple mass Replied, post #7 · Compounds › Repair & healing peptides · 16 Sep 2025 · 30 likes Why plausible mechanism is not evidence of effect: a mechanism that is chemically or biologically plausible can fail in practice for dozens of reasons —…
-
Why catalogue breadth is not evidence of anything — what changed since Replied, post #41 · Compounds › Other compounds · 10 Sep 2025 · 8 likes Distinguishing marketed research compounds from true chemical synthesis: some online suppliers sell compounds that are genuinely novel and difficult to obtain…
-
Tirzepatide and nausea: is the profile genuinely different or just differently reported? Replied, post #2 · Compounds › Tirzepatide · 4 Sep 2025 · 2 likes I read the opening post twice before replying, because I had assumed the opposite. Storage and stability: published data on licensed tirzepatide formulations exists and…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #46 · Sourcing › Vendor reports · 26 Aug 2025 · 7 likes Date the report: when the analysis was done matters. Material can degrade in storage. A report from two years ago is still useful but is not evidence about the current…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #122 · Practice › Storage & stability · 25 Aug 2025 · 0 likes Container choice matters: the material of the vial, the rubber closure, the fill volume all affect how quickly the contents degrade. Smaller fill volumes lose less to…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #114 · Compounds › Repair & healing peptides · 25 Aug 2025 · 1 like post #113 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Pages past their review date, listed Replied, post #20 · Meta › Wiki maintenance · 20 Aug 2025 · 0 likes Maintainer handovers: if a page's maintainer is inactive and needs a new one, discussing that here can facilitate the transition.
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #64 · Clinical › Special populations · 20 Aug 2025 · 27 likes Gastroparesis: pre-existing severe delayed gastric emptying can worsen with compounds that slow it further. Discussion with a clinician is prudent if this history exists.
-
Specification in the result column: why that is a meaningful error Replied, post #26 · Analytics › COA interpretation · 3 Aug 2025 · 19 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #102 · Wellbeing › Mental health · 2 Aug 2025 · 17 likes This follows post #99 rather than contradicting it. Disordered eating history: a history of anorexia, bulimia, or other eating disorders changes the risk-benefit…
-
Follow-up: Why appetite effects are mostly central Replied, post #2 · Pharmacology › Receptor biology · 17 Jul 2025 · 21 likes Bias and desensitisation: receptors can be biased (preferentially activating some downstream pathways over others) and can desensitise over time (responding less to the…
-
Thyroid function tests during substantial weight change Replied, post #6 · Clinical › Bloodwork · 15 Jul 2025 · 4 likes Reference intervals: constructed to contain the central 95% of a reference population, which means one in twenty healthy people falls outside one by definition. Add…
-
Counter-ion content and its effect on measured mass Replied, post #74 · Analytics › Mass spectrometry · 25 Jun 2025 · 24 likes Desalting before analysis: some samples need desalting to remove salts that suppress the peptide signal. Report whether desalting was used, because it can affect the…
-
Coming back to: Checking someone else's arithmetic: a worked example thread Replied, post #8 · Practice › Reconstitution · 22 Jun 2025 · 28 likes A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some preservatives crystallise in cold), is the vial being warmed gently…
-
[2026 update] Clearance pathways and what renal impairment changes Replied, post #52 · Pharmacology › Pharmacokinetics · 18 Jun 2025 · 4 likes post #51 is right about the mechanism and I think understates the practical bit. Albumin binding: semaglutide binds albumin through a fatty side chain, which sequesters…
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #53 · Evidence › Journal club · 8 Jun 2025 · 0 likes I read post #51 twice before replying, because I had assumed the opposite. SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the…
-
Sequence verification for an obscure compound: how it is done Replied, post #50 · Compounds › Other compounds · 1 Jun 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #55 · Compounds › Other compounds · 18 May 2025 · 9 likes Distinguishing marketed research compounds from true chemical synthesis: some online suppliers sell compounds that are genuinely novel and difficult to obtain…
-
A claim built entirely on a subgroup analysis Replied, post #35 · Evidence › Study critique · 15 May 2025 · 18 likes Confounding: in observational data, is there a third variable that explains the apparent association? In randomised data, randomisation should balance unknown…
-
Shakes versus food: a pragmatic assessment — the long version Replied, post #24 · Nutrition & Training › Protein & intake · 14 May 2025 · 0 likes Meeting protein targets on suppressed appetite: this is where the practical difficulty lies. Eating more protein when appetite is suppressed is genuinely hard.…
-
Lean mass preservation: what the evidence supports Replied, post #12 · Outcomes › Body composition · 11 May 2025 · 29 likes Ultrasound: thickness of subcutaneous fat at specific sites. Less standardised than DXA and operator-dependent. Useful as a supplementary measure but not as a primary…
-
Reading order for a first week here, and what to skip until later Replied, post #107 · Start Here › Welcome · 29 Apr 2025 · 0 likes The compound and evidence pages are updated regularly and they are worth reading when you are new. They answer the meta questions like "do we have data on this" and…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #83 · Devices › Cold chain · 11 Apr 2025 · 0 likes Assessing an excursion: if a package sat at room temperature for a time, visual inspection (cloudiness, discoloration, particles) can alert you to problems. Not visible…
-
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #9 · Sourcing › Vendor reports · 20 Mar 2025 · 24 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #88 · Sourcing › Vendor reports · 17 Mar 2025 · 23 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Charge states for a 4 kDa peptide, worked through Replied, post #112 · Analytics › Mass spectrometry · 15 Mar 2025 · 21 likes Electrospray ionisation produces multiply charged ions. For a 4 kDa peptide you expect mostly 2+, 3+, and 4+ charge states. Reading an electrospray spectrum means…
-
When "no data" is the complete and final answer Replied, post #117 · Compounds › Other compounds · 13 Mar 2025 · 23 likes Reading a supplier's product description as a marketing document: that is exactly what it is. The hyperbole, the mechanism written as fact, the theoretical benefits…
-
Validating a method you did not develop — does this still hold? Replied, post #40 · Analytics › Method validation · 24 Feb 2025 · 1 like Transfer between laboratories: a method can be transferred from one lab to another, but the receiving lab needs to demonstrate that they can achieve the same…
-
Distinguishing a deletion sequence by mass alone Replied, post #110 · Analytics › Mass spectrometry · 20 Feb 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Scheduled maintenance and what will be unavailable Replied, post #44 · Meta › Announcements · 15 Feb 2025 · 31 likes Implementation timeline: announcements include when a change takes effect. Marking the date helps you know whether the change is already in effect.
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #18 · Access › International · 29 Jan 2025 · 0 likes Import rules for personal use: what you can import for personal use depends on your country's rules, not on where it is sold. Checking your country's rules before…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #66 · Compounds › Semaglutide · 23 Dec 2024 · 0 likes Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects. Slowing the stomach empties it feeds less food into the intestines at a time,…
-
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #15 · Compounds › Semaglutide · 18 Dec 2024 · 27 likes I read post #13 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Why "any advice?" is the least effective ending for a post Replied, post #127 · Start Here › How to Ask · 10 Dec 2024 · 20 likes Chromatogram questions: describe the method first. Column type, gradient, wavelength, detection method. Everything else follows from method. A chromatogram without…
-
Coming back to: Renal impairment: what the labelling says about dose Replied, post #19 · Clinical › Special populations · 3 Dec 2024 · 29 likes This follows post #16 rather than contradicting it. Pregnancy and planning: these compounds are not approved for use in pregnancy. Planning windows (how long to wait…
-
Coming back to: When to suspect the method rather than the sample Replied, post #18 · Analytics › Method validation · 2 Dec 2024 · 23 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
The topic list is dense — is that deliberate? Replied, post #54 · Meta › Site feedback · 18 Nov 2024 · 24 likes Performance: if pages are slow to load, timeouts occur, or the site is unresponsive, that is worth reporting with details (when, which pages, how slow).
-
EMA product information as a primary source — does this still hold? Replied, post #3 · Regional › European Union · 14 Nov 2024 · 28 likes Worth separating two things that the opening post runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #73 · Clinical › Prescriber conversations · 8 Oct 2024 · 16 likes I read post #71 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #26 · Clinical › Comorbidities · 8 Oct 2024 · 0 likes Obstructive sleep apnoea: SURMOUNT-OSA used an objective endpoint, the apnoea-hypopnoea index. Reduction was substantial. Whether the benefit is weight loss or a direct…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #68 · Sourcing › Independent verification · 18 Sep 2024 · 0 likes Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are issued with the analytical method stated and a…
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #15 · Devices › Syringes & needles · 30 Jul 2024 · 1 like Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible for small doses. Larger barrels hold larger volumes. Choose based on…
-
How this community labels and discusses unrefereed work Replied, post #90 · Evidence › Preprints · 17 Jul 2024 · 13 likes On post #86 — agreed on the reasoning, with one qualification. Check whether it was later published: searching for the preprint's first author and keywords in PubMed…
-
Where the four-week escalation interval comes from, and what it is not Replied, post #5 · Practice › Dosing & titration · 23 May 2024 · 4 likes Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been…